Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The database of the Danish Renal Cancer Group

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. The association between rhabdomyolysis, acute kidney injury, renal replacement therapy, and mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Epidemiology of Venous Thromboembolism After Second Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Robotic versus laparoscopic urological surgery: incidence of reoperation and complications

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma-Implications for Adoptive Cell Therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Contemporary treatment of renal tumors: a questionnaire survey in the Nordic countries (the NORENCA-I study)

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Laparoscopic and robotic nephroureterectomy: does lymphadenectomy have an impact on the clinical outcome?

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Astrid Christine Petersen
  • Mette Søgaard
  • Frank Mehnert
  • Erik Højkjær Larsen
  • Frede Donskov
  • Nessn H Azawi
  • Bjarne Kromann-Andersen
View graph of relations

AIM OF THE DATABASE: The main purpose of the database of the Danish Renal Cancer Group (DaRenCaData) is to improve the quality of renal cancer treatment in Denmark and secondarily to conduct observational research.

STUDY POPULATION: DaRenCaData includes all Danish patients with a first-time diagnosis of renal cancer in the Danish National Pathology Registry since August 1, 2010.

MAIN VARIABLES: DaRenCaData holds data on demographic characteristics, treatments, and pathology collected through linkage to central registries and online registration of a few clinical key variables. Eight quality indicators have been selected for monitoring treatment quality and outcome after renal cancer.

DESCRIPTIVE DATA: The incidence of renal cancer in Denmark has increased from 12.7 per 100,000 population-years in 2010-2011 to 15.9 per 100,000 population-years in 2014-2015. A total of 3,977 Danish patients with renal cancer have been enrolled in the database in the period August 1, 2010-July 31, 2015. The completeness of data registration has increased substantially since the first years of the database. A tendency toward smaller and less advanced tumors, less invasive surgery, and a shorter hospital stay was observed, while the postoperative morbidity and mortality remained stable. Concurrently, the 1-year survival has improved and was 84.1% in 2014-2015.

CONCLUSION: DaRenCaData provides valuable information on quality of and outcome after renal cancer treatment. Efforts to improve collection and registration of data are ongoing.

Original languageEnglish
JournalClinical Epidemiology
Volume8
Pages (from-to)725-729
Number of pages5
ISSN1179-1349
DOIs
Publication statusPublished - 16 Oct 2016

ID: 49269865